Tuebingen/Wuerzburg, August 27, 2019 – Masimo, a manufacturer of noninvasive patient monitoring technologies based in Irvine, California, has closed on a strategic investment with TNI medical AG, a Wuerzburg-based commercial-stage medical device company. Funds advised by medical technology and life science investor SHS Gesellschaft für Beteiligungsmanagement became TNI medical’s lead investor in 2010. Since then, Tuebingen-based SHS has subsequently supported the company’s growth strategy.
